Cronos Group Inc. - Common Share (CRON): Price and Financial Metrics


Cronos Group Inc. - Common Share (CRON): $2.86

0.04 (+1.42%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CRON to Watchlist
Sign Up

Industry: Agriculture


Ranked

of

in industry

CRON POWR Grades


  • Growth is the dimension where CRON ranks best; there it ranks ahead of 83.71% of US stocks.
  • CRON's strongest trending metric is Momentum; it's been moving down over the last 179 days.
  • CRON's current lowest rank is in the Momentum metric (where it is better than 0.76% of US stocks).

CRON Stock Summary

  • For CRON, its debt to operating expenses ratio is greater than that reported by merely 5.41% of US equities we're observing.
  • With a year-over-year growth in debt of -72.38%, Cronos Group Inc's debt growth rate surpasses only 3.9% of about US stocks.
  • Over the past twelve months, CRON has reported earnings growth of 349.65%, putting it ahead of 93.79% of US stocks in our set.
  • If you're looking for stocks that are quantitatively similar to Cronos Group Inc, a group of peers worth examining would be GOCO, KEX, USNA, HP, and UAMY.
  • CRON's SEC filings can be seen here. And to visit Cronos Group Inc's official web site, go to www.thecronosgroup.com.

CRON Valuation Summary

  • CRON's EV/EBIT ratio is -10; this is 134.13% lower than that of the median Healthcare stock.
  • Over the past 43 months, CRON's price/sales ratio has gone down 2628.2.
  • Over the past 43 months, CRON's price/sales ratio has gone down 2628.2.

Below are key valuation metrics over time for CRON.

Stock Date P/S P/B P/E EV/EBIT
CRON 2021-08-31 43.4 1.5 -16.8 -10.0
CRON 2021-08-30 42.1 1.5 -16.3 -9.5
CRON 2021-08-27 42.5 1.5 -16.5 -9.7
CRON 2021-08-26 42.1 1.5 -16.3 -9.5
CRON 2021-08-25 42.7 1.5 -16.5 -9.8
CRON 2021-08-24 43.3 1.5 -16.7 -10.0

CRON's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • CRON has a Quality Grade of F, ranking ahead of 0.86% of graded US stocks.
  • CRON's asset turnover comes in at 0.03 -- ranking 353rd of 682 Pharmaceutical Products stocks.
  • 500 - Internal server error

The table below shows CRON's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.030 -0.621 -0.378
2021-03-31 0.027 -0.439 -0.870
2020-12-31 0.024 -0.553 -0.242
2020-09-30 0.019 -0.749 0.191
2020-06-30 0.015 -1.350 2.033
2020-03-31 0.014 -1.185 6.271

CRON Price Target

For more insight on analysts targets of CRON, see our CRON price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $6.63 Average Broker Recommendation 2.42 (Moderate Sell)

CRON Stock Price Chart Interactive Chart >

Price chart for CRON

CRON Price/Volume Stats

Current price $2.86 52-week high $8.62
Prev. close $2.82 52-week low $2.57
Day low $2.79 Volume 738,400
Day high $2.90 Avg. volume 2,189,963
50-day MA $3.00 Dividend yield N/A
200-day MA $4.03 Market Cap 1.08B

Cronos Group Inc. - Common Share (CRON) Company Bio


Cronos Group seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada’s Marihuana for Medical Purposes Regulations. The firm typically invests in companies based in Canada. Cronos Group was founded in January, 2013 and is based in Toronto, Canada.


CRON Latest News Stream


Event/Time News Detail
Loading, please wait...

CRON Latest Social Stream


Loading social stream, please wait...

View Full CRON Social Stream

Latest CRON News From Around the Web

Below are the latest news stories about Cronos Group Inc that investors may wish to consider to help them evaluate CRON as an investment opportunity.

Why Cardano, Chainlink, Cronos, and Polkadot Are Sinking Today

What happened Many cryptocurrencies are being slammed today. Cardano (CRYPTO: ADA) was sinking 7.4% as of 11:58 a.m. ET. Chainlink (CRYPTO: LINK) was down 7.5%. Cronos (CRYPTO: CRO) and Polkadot (CRYPTO: DOT) were tumbling 5.

Yahoo | February 24, 2022

Crypto.com Coin Has a New Name -- Cronos -- and Is Surging Today

Formerly the Crypto.com Coin, Cronos is the token powering Crypto.com's powerful exchange, which has grown in investor interest mainly due to a number of marketing efforts tied to the National Basketball Association as well as advertisements featuring popular celebrities. Today's price action appears to be the result of both reduced geopolitical pressures and increased investor interest around the recent rebranding of Crypto.com Coin to Cronos. As a leading cryptocurrency exchange, Crypto.com has gained a tremendous amount of interest from investors and crypto enthusiasts since its 2018 launch.

Yahoo | February 23, 2022

Cronos Group Inc. (CRON) Q3 2021 Earnings Call Transcript

At this time, I would like to turn the call over to Shayne Laidlaw, investor relations. Thank you, Catherine, and thank you for joining us today to review Cronos Group's 2021 third quarter financial and business performance. Today, I am joined by our president and CEO, Kurt Schmidt; our CFO, Bob Madore; and our executive chairman, Mike Gorenstein.

Yahoo | February 21, 2022

Is This SPAC a Buy After Falling More Than 50%?

Synthetic biology used to be something you saw in the movies, such as Jurassic Park when they use preserved DNA to bring dinosaurs back to life. The stock came public via a SPAC merger at a time when the markets were at a near-fever pitch for new and speculative companies. Since going public, the stock has cratered, falling almost 50% from its SPAC price of $10 per share.

Yahoo | February 18, 2022

Cronos Group net income falls, launches cost-cutting measures

Cronos Group said Friday its third-quarter net income fell to $55.1 million, or 21 cents a share, from $95.2 million, or 18 cents a share, in the year-ago period. The latest quarter includes a $132.9 million gain on revaluation of derivative liabilities. Third-quarter net revenue at the cannabis company rose by $9 million to $20.4 million on growth in the Canadian adult use market, and increased cannabis sales in the U.S. and Israeli markets. Analysts expected a loss of 11 cents a share and sale

Yahoo | February 18, 2022

Read More 'CRON' Stories Here

CRON Price Returns

1-mo -1.72%
3-mo -27.04%
6-mo -30.41%
1-year -65.75%
3-year -81.23%
5-year N/A
YTD -27.04%
2021 -43.52%
2020 -9.52%
2019 -26.18%
2018 34.43%
2017 600.87%

Continue Researching CRON

Here are a few links from around the web to help you further your research on Cronos Group Inc's stock as an investment opportunity:

Cronos Group Inc (CRON) Stock Price | Nasdaq
Cronos Group Inc (CRON) Stock Quote, History and News - Yahoo Finance
Cronos Group Inc (CRON) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.5556 seconds.